1. Home
  2. KZIA vs AMBO Comparison

KZIA vs AMBO Comparison

Compare KZIA & AMBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KZIA
  • AMBO
  • Stock Information
  • Founded
  • KZIA 1994
  • AMBO 2000
  • Country
  • KZIA Australia
  • AMBO United States
  • Employees
  • KZIA N/A
  • AMBO N/A
  • Industry
  • KZIA Biotechnology: Pharmaceutical Preparations
  • AMBO Other Consumer Services
  • Sector
  • KZIA Health Care
  • AMBO Real Estate
  • Exchange
  • KZIA Nasdaq
  • AMBO Nasdaq
  • Market Cap
  • KZIA 6.0M
  • AMBO 7.1M
  • IPO Year
  • KZIA 1999
  • AMBO 2010
  • Fundamental
  • Price
  • KZIA $0.77
  • AMBO $2.48
  • Analyst Decision
  • KZIA Strong Buy
  • AMBO
  • Analyst Count
  • KZIA 2
  • AMBO 0
  • Target Price
  • KZIA $11.50
  • AMBO N/A
  • AVG Volume (30 Days)
  • KZIA 334.9K
  • AMBO 20.9K
  • Earning Date
  • KZIA 04-11-2025
  • AMBO 12-30-2024
  • Dividend Yield
  • KZIA N/A
  • AMBO N/A
  • EPS Growth
  • KZIA N/A
  • AMBO N/A
  • EPS
  • KZIA N/A
  • AMBO 0.11
  • Revenue
  • KZIA $1,655,324.00
  • AMBO $9,392,000.00
  • Revenue This Year
  • KZIA N/A
  • AMBO N/A
  • Revenue Next Year
  • KZIA N/A
  • AMBO N/A
  • P/E Ratio
  • KZIA N/A
  • AMBO $23.61
  • Revenue Growth
  • KZIA 248000.00
  • AMBO 2.50
  • 52 Week Low
  • KZIA $0.76
  • AMBO $1.00
  • 52 Week High
  • KZIA $15.80
  • AMBO $5.55
  • Technical
  • Relative Strength Index (RSI)
  • KZIA 35.51
  • AMBO 47.68
  • Support Level
  • KZIA $0.76
  • AMBO $2.43
  • Resistance Level
  • KZIA $1.05
  • AMBO $3.20
  • Average True Range (ATR)
  • KZIA 0.08
  • AMBO 0.35
  • MACD
  • KZIA -0.00
  • AMBO -0.05
  • Stochastic Oscillator
  • KZIA 3.84
  • AMBO 12.96

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is a provider of educational and career enhancement services in China. It operates through CP&CE Programs. The CP&CE Programs include tutoring services and career enhancement services. Geographically all the operations function in the United States and Foreign countries.

Share on Social Networks: